{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:19:39Z","timestamp":1780571979364,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["847845"],"award-info":[{"award-number":["847845"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["50-53125-98-034"],"award-info":[{"award-number":["50-53125-98-034"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.tvr.2022.200240","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T12:01:21Z","timestamp":1653739281000},"page":"200240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer \u226515 years later"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3661-0842","authenticated-orcid":false,"given":"Federica","family":"Inturrisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Bogaards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A.M.","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2022.200240_bib1","series-title":"Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","year":"1995"},{"issue":"Suppl 1","key":"10.1016\/j.tvr.2022.200240_bib2","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 10","key":"10.1016\/j.tvr.2022.200240_bib3","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.tvr.2022.200240_bib4","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","article-title":"Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity","volume":"70","author":"Trottier","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tvr.2022.200240_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-1609","article-title":"Effect of several negative rounds of human papillomavirus and cytology Co-testing on safety against cervical cancer: an observational cohort study","volume":"168","author":"Castle","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.tvr.2022.200240_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infec."},{"key":"10.1016\/j.tvr.2022.200240_bib7","series-title":"Risk-based Screening for Cervical Cancer in Europe","author":"Donken","year":"2021"},{"issue":"1","key":"10.1016\/j.tvr.2022.200240_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.tvr.2022.200240_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"9601","key":"10.1016\/j.tvr.2022.200240_bib10","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tvr.2022.200240_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","article-title":"GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes","volume":"40","author":"van den Brule","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.tvr.2022.200240_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.44.2.504-512.2006","article-title":"Bead-based multiplex genotyping of human papillomaviruses","volume":"44","author":"Schmitt","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.tvr.2022.200240_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jnci\/djy192","article-title":"Role of screening history in clinical meaning and optimal management of positive cervical screening results","volume":"111","author":"Castle","year":"2019","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679022000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679022000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:53:56Z","timestamp":1763006036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679022000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":13,"alternative-id":["S2666679022000064"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2022.200240","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer \u226515 years later","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2022.200240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200240"}}